buflomedil has been researched along with Brain Vascular Disorders in 11 studies
buflomedil: RN given refers to parent cpd; synonym LL 1656 refers to HCl; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seventy-six patients took part in a randomized, comparative study of the efficacy of buflomedil hydrochloride and dihydrogenated ergot alkaloids in the treatment of senile dementia associated with cerebrovascular insufficiency." | 9.05 | The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids. ( Bruckner, GW; Jansen, P; Jansen, W, 1985) |
| "Buflomedil hydrochloride is a vasoactive drug with a variety of pharmacodynamic properties." | 7.76 | Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases. ( Clissold, SP; Lynch, S; Sorkin, EM, 1987) |
| "Buflomedil chlorhydrate is a newly synthesized molecule with a notable effect of vasodilatation even on cerebral blood vessels." | 6.66 | [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. ( Ciuffetti, G; Lombardini, R; Mercuri, M; Palazzetti, D; Parnetti, L; Rizzo, MT, 1989) |
| "Seventy-six patients took part in a randomized, comparative study of the efficacy of buflomedil hydrochloride and dihydrogenated ergot alkaloids in the treatment of senile dementia associated with cerebrovascular insufficiency." | 5.05 | The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids. ( Bruckner, GW; Jansen, P; Jansen, W, 1985) |
| "Buflomedil hydrochloride is a vasoactive drug with a variety of pharmacodynamic properties." | 3.76 | Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases. ( Clissold, SP; Lynch, S; Sorkin, EM, 1987) |
| "Buflomedil chlorhydrate is a newly synthesized molecule with a notable effect of vasodilatation even on cerebral blood vessels." | 2.66 | [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. ( Ciuffetti, G; Lombardini, R; Mercuri, M; Palazzetti, D; Parnetti, L; Rizzo, MT, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaha, L | 1 |
| Dubourg, A | 1 |
| Scamuffa, RF | 1 |
| Demichelis Genesio, MA | 1 |
| Sanz, MC | 1 |
| Pacheco e Silva, A | 1 |
| Landi de Almedia, AM | 1 |
| Lombardini, R | 2 |
| Ciuffetti, G | 2 |
| Paltriccia, R | 1 |
| Scarponi, AM | 1 |
| Savastano, V | 1 |
| Palazzetti, D | 2 |
| Mercuri, M | 2 |
| Parnetti, L | 2 |
| Rizzo, MT | 1 |
| Bossi, E | 1 |
| Bossi, L | 2 |
| Clissold, SP | 1 |
| Lynch, S | 1 |
| Sorkin, EM | 1 |
| Jansen, W | 1 |
| Bruckner, GW | 1 |
| Jansen, P | 1 |
| Salerno, L | 1 |
| Sallì, L | 1 |
| Pepe, S | 1 |
| Curiale, B | 1 |
| Allegra, G | 1 |
| Scalici, G | 1 |
| Salvato, F | 1 |
2 reviews available for buflomedil and Brain Vascular Disorders
| Article | Year |
|---|---|
An experimental overview of a new vasoactive drug: buflomedil HCl.
Topics: Animals; Cerebrovascular Disorders; Chronic Disease; Coronary Disease; Dogs; Hemodynamics; Humans; I | 1981 |
Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
Topics: Adult; Aged; Animals; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Kinetics; Pyrroli | 1987 |
7 trials available for buflomedil and Brain Vascular Disorders
| Article | Year |
|---|---|
[Monitoring therapy in the treatment of cerebrovascular insufficiency].
Topics: Bencyclane; Cerebrovascular Disorders; Cinnarizine; Double-Blind Method; Humans; Nicergoline; Pyrrol | 1983 |
Evaluation of buflomedil in geriatric patients suffering from vascular cerebral insufficiency.
Topics: Aged; Aging; Cerebrovascular Disorders; Clinical Trials as Topic; Ergot Alkaloids; Female; Hemodynam | 1981 |
Double blind comparative study of cinnarizine and buflomedil in patients suffering from cerebrovascular insufficiency.
Topics: Aged; Blood Pressure; Cerebrovascular Disorders; Cholesterol; Cinnarizine; Double-Blind Method; Fema | 1981 |
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
Topics: Aged; Cerebrovascular Disorders; Chronic Disease; Clinical Trials as Topic; Erythrocyte Deformabilit | 1989 |
Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
Topics: Adult; Aged; Animals; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Kinetics; Pyrroli | 1987 |
The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
Topics: Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Dementia; Dihydroergotoxine; Female; Huma | 1985 |
[Stroke and post-ictal states].
Topics: Brain Edema; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Disorders; Clinical Trials as Topi | 1985 |
3 other studies available for buflomedil and Brain Vascular Disorders
| Article | Year |
|---|---|
[Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases].
Topics: Aged; Blood Viscosity; Cerebrovascular Disorders; Chronic Disease; Erythrocyte Deformability; Female | 1989 |
[Acute and chronic cerebrovascular diseases. A therapeutic approach].
Topics: Brain; Brain Ischemia; Cerebrovascular Disorders; Electroencephalography; Humans; Pyrrolidines; Tomo | 1989 |
[Treatment of chronic cerebrovascular insufficiency and chronic obliterating arteriopathy of the lower extremities with buflomedil hydrochloride].
Topics: Aged; Anorexia; Arteriosclerosis Obliterans; Cerebrovascular Disorders; Drug Tolerance; Female; Head | 1985 |